The global 3D printing medical devices market, valued at USD 3.64 billion in 2024, is projected to reach USD 4.37 billion in 2025 and USD 18.84 billion by 2035, representing a CAGR of 15.7% during the forecast period. Driven by the growing understanding of 3D printing technology in the medical industry, several market players are actively engaging in the industry for providing innovative printing solutions. For instance, in November 2024, HP revealed groundbreaking innovations in metal 3D printi...

The global contrast media market, valued at USD 6.38 billion in 2024, is expected to grow to USD 6.83 billion in 2025 and USD 11.88 billion by 2035, representing a CAGR of 5.7% during the forecast period. According to the recent report of Centers for Disease Control and Prevention, over 944,800 Americans die due to heart stroke annually and around 90% (approximately USD 4.5 trillion) of nations healthcare expenditure is dedicated to people with mental and chronic health conditions. With the grow...

The global nurse call systems market, valued at USD 2.28 billion in 2024, is projected to reach USD 2.56 billion in 2025 and USD 6.73 billion by 2035, representing a CAGR of 10.2% during the forecast period. Considering the ongoing necessity, several industrial players have undertaken strategic initiatives in this field to develop advanced nurse call software and solutions to enhance patient care and optimize nurse workflow. For instance, in October 2024, Abridge, Mayo Clinic and Epic conjointly...

The diabetes care devices market size is projected to grow from USD 39.82 billion in 2025 to USD 99.81 billion by 2035, representing a CAGR of 9.62% during the forecast period till 2035. Over the course of decades, the diabetes care device market has reached new heights of expansion driven by the growing number of diabetic patients worldwide. According to a report, approximately 800 million people have diabetes around the world. Diabetes rates in adults doubled from about 7% to 14% between 1990...

The global wearable medical devices market is valued at USD 39.31 billion in 2025 and is estimated to reach USD 232.98 billion by 2035, representing a CAGR of 19.48% during the forecast period. In August 2024, Re-Time launched retimer 3, a smart sleep wearable, to support the people dealing with poor circadian rhythms. In the same month, HUAWEI launched HUAWEI TruSense system, a digital health and fitness sensor technology, that will support continuous vital monitoring. Examples of key players e...

The global flow cytometry market size is valued at USD 5.1 billion in 2024 and is poised to reach USD 10.75 billion in 2032, representing a CAGR of 8.25% during the forecast period. Based on the type of product, the market for flow cytometry is split into reagents and consumables, flow cytometry instruments, accessories, flow cytometry services, and software. Reagents and consumables are expected to dominate the segment with more than 54% of the total flow cytometry market share in 2024. The adv...

The global in vitro diagnostics market, valued at USD 113 billion in 2025, is projected to reach USD 118 billion in 2026 and USD 190 billion by 2035, with a 5.4% CAGR during the forecast period 2026 to 2035. The laboratory segment holds the highest share (~85%) of the market. With regards to type of offering, the reagents segment dominates the global market with 75% of the market share. Based on the type of technology, the immunoassay segment holds the largest market share (nearly 35%) in 202...

The global smart insulin pens market is valued at USD 4.31 billion in 2024 and is poised to reach USD 10.36 billion by 2035, representing a CAGR of 8.30% during the forecast period. On the basis of geographical regions, the global smart insulin pens market value is distributed across North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America. According to our market analysis, presently North America holds the highest share (35%) of the market, driven by the growing case...

The global automated suturing devices market is estimated to grow from 3.40 billion in 2024 to USD 6.60 billion by 2035, at a CAGR of 6.20% during the forecast period, till 2035. The global market is propelled by various factors such as growing demand for minimally invasive treatment and rising risk of chronic conditions. A recent report of Centers for Disease Control and Prevention stated that, nearly 129 million people in United States are suffering from at least one chronic disease. Therefore...

The medical exoskeleton market, valued at USD 1.41 billion in 2025, is projected to grow to USD 1.79 billion in 2026 and USD 8.70 billion by 2035, representing a CAGR of 19.2% during the forecast period. Medical exoskeletons are wearable robotic devices designed to assist individuals with mobility impairments. They use a combination of mechanical, electronic, and computer-controlled systems to support and enhance the user's movement, typically targeting specific body parts affected by injury or...

The global veterinary ultrasound market is valued at USD 0.43 billion in 2024 and is poised to reach USD 0.73 billion by 2035, representing a CAGR of 4.96% during the forecast period.

The global medical device market size is anticipated to increase from USD 528.88 billion in 2024 to reach USD 857.39 billion by 2035, growing at a CAGR of 4.49% during the forecast period. In November 2024, Boston Scientific acquired Axonics, a medical technology company focused on development of devices for the treatment of bowel and urinary dysfunction. As stated by Meghan Scanlon, Senior Vice President and President, Urology, Boston Scientific,

The global malaria diagnostics market size is valued at USD 0.85 billion in 2024 and is projected to reach USD 1.45 billion by 2035, representing a CAGR of 5.0% during the forecast period. As per the World Health Organization (WHO) report, in 2022, nearly 6,08,000 people died due to malaria and 249 million new cases were reported in 2022. Of these, 94% cases were identified in the African region. In order to mitigate the growing concern of malaria, WHO has recommended early parasite-based diagno...

The medical aesthetics market, valued at USD 37.6 billion in 2024, is project to reach USD 40.9 billion in 2025 and USD 102.3 billion by 2035, representing a CAGR of 9.6% during the forecast period 2025 to 2035. Based on the end user, the clinics / medical spas, dermatology centers / cosmetic centers segment holds the largest market share (nearly 50%) in 2025. With respect to gender, females capture the highest share (90%). North America captures majority of the market share. Notably, Asia-Pacif...

The global home healthcare market size is valued at USD 311.66 billion in 2024 and is projected to reach USD 719.31 billion by 2035, representing a CAGR of 7.90% during the forecast period. North America currently accounts for the highest share (51%) of the market. Currently, services occupy an 85% share of the market with products accounting for the rest. The global market for home healthcare will also be propelled by increasing patient preferences for remote care and technological advancements...

The global rehabilitation robots market size is estimated to grow from USD 0.29 billion in 2024 to USD 1.33 billion by 2035, representing a CAGR of 15% during the forecast period. In 2024, the World Health Organization reported that more than 15 million people are living with spinal cord injuries and the majority of these causes are due to accidental falls, road accidents and trauma. This rising incidence of spinal cord injuries has underscored the demand for rehabilitation robots, specifically...

The smart inhalers market size is valued at USD 1.53 billion in 2024 and is expected to reach USD 5.84 billion by 2035, representing a CAGR of 12.95% during the forecast period 2024-2035. According to our projection, currently hospital pharmacies occupy the highest share (nearly 45%) of the market owing to flexibility, convenience and comfort of purchasing smart inhalers in the healthcare settings for hospitalized patients. Furthermore, there is an increase in the number of hospitalized patients...

The global drug delivery technologies market is currently valued at $0.52 billion and is poised to reach $6.42 billion by 2035, at a CAGR of 25.5%, during the forecast period. Given the inherent requirement for frequent medication, patients suffering from such long-lasting clinical conditions generally end up spending high amounts on not only the prescribed therapeutic regimen, but also on numerous hospital visits for dose administration. Since 2018, more than 250 biologics (including antibody d...

The global surgical sutures market is estimated to grow from $4.79 billion in 2024 to $8.70 billion by 2035, at a steady CAGR of 5.57% during the forecast period. In September 2024, Meril announced the launch of New Edge suture that has enhanced durability, precision and reliability and minimizes the risk of complication and re-surgery. Further, in October 2024, Globus Medical announced the launch of TENSOR